Efficacy and Toxicity of Weekly Carboplatin and Paclitaxel as Induction or Palliative Treatment in Advanced Esophageal Cancer Patients

Efficacy and Toxicity of Weekly Carboplatin and Paclitaxel as Induction or Palliative Treatment in Advanced Esophageal Cancer Patients

Many patients have advanced esophageal cancer at diagnosis. However, the most optimal treatment has not been identified. Therefore, we evaluated a weekly regimen of carboplatin (area under the curve (AUC)) of 4 and paclitaxel at 100 mg/m<sup>2</sup> as an induction or palliative treatmen...

Full description

Bibliographic Details
Main Authors: Femke M. de Man, Ruben A.G. van Eerden, Esther Oomen-de Hoop, Joris N. Veraart, Nadia van Doorn, Leni van Doorn, Ate van der Gaast, Ron H.J. Mathijssen
Format: Article
Language:English
Published: MDPI AG 2019-06-01
Series:Cancers
Subjects:
esophageal cancer
induction treatment
palliative treatment
efficacy
toxicity
Online Access:https://www.mdpi.com/2072-6694/11/6/826

Internet

https://www.mdpi.com/2072-6694/11/6/826

Similar Items